Efficacy and Safety of the ACAT Inhibitor CS-505 (Pactimibe) for Reducing the Progression of Coronary Artery Disease

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2002
The purpose of this study is to learn if CS-505 is safe and effective for slowing down or possibly reversing the buildup of tissue, cells and fatty deposits (plaque) in the blood vessels of the heart (coronary artery atherosclerosis).
Epistemonikos ID: 65ca96325b6c735008ebcc7e6a31d578dddd8d8e
First added on: May 04, 2024